Allegis Investment Advisors’s AbbVie ABBV Stock Holding History

Allegis Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$983K	Sell	10,384 -212	-2%	-$23.3K	0.3%	76
2017 Q4	$1.02M	Sell	10,596 -10,197	-49%	-$961K	0.3%	92
2017 Q3	$1.85M	Buy	20,793 +1,806	+10%	+$137K	0.44%	67
2017 Q2	$1.38M	Buy	18,987 +1,799	+10%	+$121K	0.35%	87
2017 Q1	$1.12M	Buy	17,188 +2,648	+18%	+$166K	0.29%	88
2016 Q4	$910K	Buy	14,540 +3,377	+30%	+$206K	0.29%	99
2016 Q3	$704K	Buy	+11,163	New	+$723K	0.27%	112
2016 Q1	–	Sell	-968	Closed	-$57K	–	194
2015 Q4	$57K	Buy	+968	New	+$55.8K	0.03%	309

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Allegis Investment Advisors's ABBV Position: Q1 2018 in Review

Allegis Investment Advisors reduced its AbbVie (ABBV) stake by 2% in Q1 2018, selling an estimated $23.3K and leaving 10,384 shares worth $983K. The position accounts for 0.3% of the portfolio, ranked #76.

Allegis Investment Advisors first reported a position in ABBV in Q4 2015 and has held it in 8 quarters since. The position peaked at $1.85M in Q3 2017. 2,016 funds tracked by Wall St. Rank hold ABBV as of Q1 2018.

Allegis Investment Advisors held 10,384 shares of AbbVie worth $983K as of Q1 2018.
Allegis Investment Advisors sold 212 AbbVie shares in Q1 2018, an estimated $23.3K.
AbbVie made up 0.3% of Allegis Investment Advisors's portfolio in Q1 2018, its #76 holding.
Allegis Investment Advisors first reported a position in AbbVie in Q4 2015 and has held it in 8 quarters since.
Allegis Investment Advisors's AbbVie position peaked at $1.85M in Q3 2017.
2,016 funds tracked by Wall St. Rank held AbbVie as of Q1 2018.

Based on Allegis Investment Advisors's 13F filing for Q1 2018, filed 24 Apr 2018.